US2010331401A1PendingUtilityA1

Antimicrobial and antiinflammatory composition

42
Assignee: DENOVASTELLA ABPriority: Jul 1, 2005Filed: Sep 1, 2010Published: Dec 30, 2010
Est. expiryJul 1, 2025(expired)· nominal 20-yr term from priority
A61P 31/10A61P 31/12A61P 29/00A61P 31/00A61P 31/04A61P 31/22A61P 17/00A61K 8/9728A61K 8/9789A61K 36/28A61Q 19/00A61Q 5/006A61K 8/11A61K 8/0208A61K 31/343A61Q 17/005A61K 8/4973A61Q 19/10A61Q 5/02A61K 36/282A61K 8/498A61K 31/341A61K 31/047A61K 31/352
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the use of at least davanone and 1,8-cineol for the manufacture of an antimicrobial and/or antiinflammatory composition as well as a method of producing said composition.

Claims

exact text as granted — not AI-modified
1 . A method of treating a microbial and/or inflammatory disease in a subject in need thereof, comprising:
 administering to the subject a composition comprising:
 0.0025 to 1.0% (w/v) of a combination of davanone and 1,8 cineol; 
 0.1 to 100 μg/ml casticin; 
 0.1 to 100 μg/ml centaureidin; 
 0.1 to 100 μg/ml quercetin 3,4-dimethyl ether; and 
 0.1 to 100 μg/ml quercetin 3,7-dimethyl ether. 
   
     
     
         2 . The method of  claim 1 , wherein the disease is herpes simplex infection, tinea pedis, impetigo, dandruff, or pityriasis versicolor infection. 
     
     
         3 . The method of  claim 1 , wherein the composition is in the form of a gel, spray, shampoo, or cream. 
     
     
         4 . The method of  claim 3 , wherein the composition is in the form of a gel or a cream. 
     
     
         5 . The method of  claim 1 , wherein the davanone is from  A. pallens , the 1,8-cineol is from  Eucalyptus globulus , and the flavonols are from  A. abrotanum.    
     
     
         6 . The method of  claim 5 , wherein the davanone, 1,8-cineol and flavonols are from  A. abrotanum.    
     
     
         7 . The method of  claim 1 , wherein the davanone, 1,8-cineola, and flavonols are from one or more plants selected from the group consisting of  A. oelandicum, A. dracunculus, A. campestris, A. vulgaris, A. absinthium, A. stelleriana, A. rupestris, A. abrotanum, A. pallens, A. lerchiana, A. thuscula, A. rehan, A. persica, A. glabella, Lantana camara  and  Tanacetum vulgare.    
     
     
         8 . The method of  claim 7 , wherein the disease is herpes simplex infection, tinea pedis, impetigo, dandruff, or pityriasis versicolor infection. 
     
     
         9 . The method of  claim 7 , wherein the composition is in the form of a gel, spray, shampoo, or cream. 
     
     
         10 . The method of  claim 9 , wherein the composition is in the form of a gel or a cream. 
     
     
         11 . The method of  claim 7 , wherein the davanone is from  A. pallens , the 1,8-cineol is from  Eucalyptus globulus , and the flavonols are from  A. abrotanum.    
     
     
         12 . The method of  claim 7 , wherein the davanone, 1,8-cineol and flavonols are from  A. abrotanum.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.